Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Molecular Cancer Therapeutics|July 5, 2006
Functional analysis and molecular modeling show a preserved wild-type activity of p53(C238Y)Marco Ferrone, Federica Perrone, Elena Tamborini, et al.
European Journal of Immunology|March 17, 2005
Damaging-agent sensitivity of Artemis-deficient cell linesAntonio Musio, Veronica Marrella, Cristina Sobacchi, et al.
Oncotarget|June 4, 2016
The isopeptidase inhibitor 2cPE triggers proteotoxic stress and ATM activation in chronic lymphocytic leukemia cellsAndrea Tomasella, Raffaella Picco, Sonia Ciotti, et al.
Scientific Reports|January 26, 2019
DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patientsAlessandro Corti, Raina Sota, Matteo Dugo, et al.
Nature Aging|September 5, 2025
A blood-based DNA damage signature in patients with Parkinson's disease is associated with disease progressionDaisy Sproviero, César Payán-Gómez, Chiara Milanese, et al.
International Journal of Hematology|August 26, 2009
Phenotypic variations between affected siblings with ataxia-telangiectasia: ataxia-telangiectasia in JapanTomohiro Morio, Naomi Takahashi, Fumiaki Watanabe, et al.
Human Molecular Genetics|November 11, 2008
Cornelia de Lange syndrome mutations in SMC1A or SMC3 affect binding to DNAEkaterina Revenkova, Maria Luisa Focarelli, Lucia Susani, et al.
Nucleic Acids Research|November 23, 2017
Separase prevents genomic instability by controlling replication fork speedFrancesco Cucco, Elisa Palumbo, Serena Camerini, et al.
Cancer Research|September 1, 2011
TLR9 agonists oppositely modulate DNA repair genes in tumor versus immune cells and enhance chemotherapy effectsMichele Sommariva, Loris De Cecco, Michelandrea De Cesare, et al.
Pageof 8